tiprankstipranks
GH Research (DE:1KA)
FRANKFURT:1KA
Germany Market
1KA
GH Research
RESEARCH TOOLSreports

GH Research (1KA) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

1KA Analyst Ratings

Strong Buy
9Ratings
Strong Buy
9 Buy
0 Hold
0 Sell
Based on 9 analysts giving stock ratings to
GH
Research
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

1KA Stock 12 Month Forecast

Average Price Target

€37.17
▲(53.59% Upside)
Based on 9 Wall Street analysts offering 12 month price targets for GH Research in the last 3 months. The average price target is €37.17 with a high forecast of €55.70 and a low forecast of €32.56. The average price target represents a 53.59% change from the last price of €24.20.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"9":"€9","56":"€56","20.75":"€20.8","32.5":"€32.5","44.25":"€44.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":55.6982764,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€55.70</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":37.16788829,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€37.17</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":32.56206928,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€32.56</span>\n  </div></div>","useHTML":true}}],"tickPositions":[9,20.75,32.5,44.25,56],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,24.2,26.622944338461537,29.045888676923077,31.468833015384615,33.89177735384615,36.314721692307685,38.737666030769226,41.16061036923077,43.5835547076923,46.00649904615384,48.42944338461538,50.852387723076916,53.27533206153846,{"y":55.6982764,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,24.2,25.197529868461537,26.195059736923078,27.192589605384615,28.190119473846153,29.187649342307694,30.18517921076923,31.18270907923077,32.18023894769231,33.17776881615384,34.175298684615385,35.172828553076926,36.17035842153847,{"y":37.16788829,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,24.2,24.84323609846154,25.486472196923078,26.129708295384617,26.772944393846153,27.416180492307692,28.05941659076923,28.70265268923077,29.34588878769231,29.989124886153846,30.63236098461539,31.275597083076924,31.918833181538464,{"y":32.56206928,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":12.2,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.9,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.8,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.5,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.4,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.3,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.6,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.3,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.8,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.9,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.6,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.2,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€55.70Average Price Target€37.17Lowest Price Target€32.56
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on DE:1KA
Patrick Trucchio
H.C. Wainwright
H.C. Wainwright
€55.7
Buy
130.16%
Upside
Reiterated
08/10/26
Analyst Reiterates Buy on GH Research as GH001 Advances Toward Phase 3; $65 Price Target Maintained
TD Cowen Analyst forecast on DE:1KA
Ritu Baral
TD Cowen
TD Cowen
―
Buy
―
Reiterated
08/06/26
GH Research Earns Buy Rating on FDA Phase 3 Green Light, Strong TRD Strategy and Solid Cash Runway
Needham Analyst forecast on DE:1KA
Ami Fadia
Needham
Needham
€27.42→€33.42
Buy
38.09%
Upside
Reiterated
08/06/26
Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (NASDAQ: PRAX), BioCryst (NASDAQ: BCRX) and GH Research (NASDAQ: GHRS)
Cantor Fitzgerald Analyst forecast on DE:1KA
Joshua Schimmer
Cantor Fitzgerald
Cantor Fitzgerald
€29.99→€34.28
Buy
41.64%
Upside
Reiterated
08/06/26
GH Research price target raised to $40 from $35 at Cantor FitzgeraldGH Research price target raised to $40 from $35 at Cantor Fitzgerald
Stifel Nicolaus Analyst forecast on DE:1KA
Paul Matteis
Stifel Nicolaus
Stifel Nicolaus
€32.56
Buy
34.55%
Upside
Reiterated
08/06/26
Analysts' Top Healthcare Picks: Dianthus Therapeutics (DNTH), Elanco Animal Health (ELAN)
RBC Capital Analyst forecast on DE:1KA
Brian Abrahams
RBC Capital
RBC Capital
€34.28→€35.99
Buy
48.72%
Upside
Reiterated
08/06/26
RBC Capital Remains a Buy on GH Research (GHRS)
Canaccord Genuity Analyst forecast on DE:1KA
Sumant Kulkarni
Canaccord Genuity
Canaccord Genuity
€33.42
Buy
38.09%
Upside
Reiterated
08/06/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: InMode (NASDAQ: INMD), GH Research (NASDAQ: GHRS) and Scholar Rock Holding (NASDAQ: SRRK)
Guggenheim Analyst forecast on DE:1KA
Eddie Hickman
Guggenheim
Guggenheim
€29.13→€34.28
Buy
41.64%
Upside
Reiterated
08/06/26
GH Research price target raised to $40 from $34 at GuggenheimGH Research price target raised to $40 from $34 at Guggenheim
Wells Fargo Analyst forecast on DE:1KA
Benjamin Burnett
Wells Fargo
Wells Fargo
€37.7
Buy
55.80%
Upside
Initiated
07/27/26
GH Research initiated with an Overweight at Wells FargoGH Research initiated with an Overweight at Wells Fargo
Citizens JMP Analyst forecast on DE:1KA
Jason Butler
Citizens JMP
Citizens JMP
€35.99→€33.42
Buy
38.09%
Upside
Reiterated
05/15/26
GH Research price target lowered to $39 from $42 at CitizensGH Research price target lowered to $39 from $42 at Citizens
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on DE:1KA
Patrick Trucchio
H.C. Wainwright
H.C. Wainwright
€55.7
Buy
130.16%
Upside
Reiterated
08/10/26
Analyst Reiterates Buy on GH Research as GH001 Advances Toward Phase 3; $65 Price Target Maintained
TD Cowen Analyst forecast on DE:1KA
Ritu Baral
TD Cowen
TD Cowen
―
Buy
―
Reiterated
08/06/26
GH Research Earns Buy Rating on FDA Phase 3 Green Light, Strong TRD Strategy and Solid Cash Runway
Needham Analyst forecast on DE:1KA
Ami Fadia
Needham
Needham
€27.42→€33.42
Buy
38.09%
Upside
Reiterated
08/06/26
Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (NASDAQ: PRAX), BioCryst (NASDAQ: BCRX) and GH Research (NASDAQ: GHRS)
Cantor Fitzgerald Analyst forecast on DE:1KA
Joshua Schimmer
Cantor Fitzgerald
Cantor Fitzgerald
€29.99→€34.28
Buy
41.64%
Upside
Reiterated
08/06/26
GH Research price target raised to $40 from $35 at Cantor FitzgeraldGH Research price target raised to $40 from $35 at Cantor Fitzgerald
Stifel Nicolaus Analyst forecast on DE:1KA
Paul Matteis
Stifel Nicolaus
Stifel Nicolaus
€32.56
Buy
34.55%
Upside
Reiterated
08/06/26
Analysts' Top Healthcare Picks: Dianthus Therapeutics (DNTH), Elanco Animal Health (ELAN)
RBC Capital Analyst forecast on DE:1KA
Brian Abrahams
RBC Capital
RBC Capital
€34.28→€35.99
Buy
48.72%
Upside
Reiterated
08/06/26
RBC Capital Remains a Buy on GH Research (GHRS)
Canaccord Genuity Analyst forecast on DE:1KA
Sumant Kulkarni
Canaccord Genuity
Canaccord Genuity
€33.42
Buy
38.09%
Upside
Reiterated
08/06/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: InMode (NASDAQ: INMD), GH Research (NASDAQ: GHRS) and Scholar Rock Holding (NASDAQ: SRRK)
Guggenheim Analyst forecast on DE:1KA
Eddie Hickman
Guggenheim
Guggenheim
€29.13→€34.28
Buy
41.64%
Upside
Reiterated
08/06/26
GH Research price target raised to $40 from $34 at GuggenheimGH Research price target raised to $40 from $34 at Guggenheim
Wells Fargo Analyst forecast on DE:1KA
Benjamin Burnett
Wells Fargo
Wells Fargo
€37.7
Buy
55.80%
Upside
Initiated
07/27/26
GH Research initiated with an Overweight at Wells FargoGH Research initiated with an Overweight at Wells Fargo
Citizens JMP Analyst forecast on DE:1KA
Jason Butler
Citizens JMP
Citizens JMP
€35.99→€33.42
Buy
38.09%
Upside
Reiterated
05/15/26
GH Research price target lowered to $39 from $42 at CitizensGH Research price target lowered to $39 from $42 at Citizens
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ODTXOdyssey Therapeutics, Inc.
BTSGBrightSpring Health Services, Inc.
GPCRStructure Therapeutics, Inc. Sponsored ADR
AMLXAmylyx Pharmaceuticals Inc
IMMXImmix Biopharma
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering GH Research

3 Months
Patrick TrucchioH.C. Wainwright
Success Rate
11/18 ratings generated profit
61%
Average Return
+10.74%
Copying Patrick Trucchio's trades and holding each position for 3 Months would result in 61.11% of your transactions generating a profit, with an average return of +10.74% per trade.
1 Year
Patrick TrucchioH.C. Wainwright
Success Rate
16/18 ratings generated profit
89%
Average Return
+71.83%
Copying Patrick Trucchio's trades and holding each position for 1 Year would result in 88.89% of your transactions generating a profit, with an average return of +71.83% per trade.
2 Years
Patrick TrucchioH.C. Wainwright
Success Rate
17/18 ratings generated profit
94%
Average Return
+123.51%
Copying Patrick Trucchio's trades and holding each position for 2 Years would result in 94.44% of your transactions generating a profit, with an average return of +123.51% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

1KA Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
10
15
7
6
2
Buy
1
3
2
2
7
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
11
18
9
8
9
In the current month, 1KA has received 9 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 1KA average Analyst price target in the past 3 months is 37.17.
Each month's total comprises the sum of three months' worth of ratings.

1KA Financial Forecast

1KA Earnings Forecast

Next quarter’s earnings estimate for 1KA is -€0.27 with a range of -€0.37 to -€0.19. The previous quarter’s EPS was -€0.20. 1KA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 1KA has Performed in-line its overall industry.
Next quarter’s earnings estimate for 1KA is -€0.27 with a range of -€0.37 to -€0.19. The previous quarter’s EPS was -€0.20. 1KA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 1KA has Performed in-line its overall industry.
No data currently available

1KA Sales Forecast

Next quarter’s sales forecast for 1KA is €0.00 with a range of €0.00 to €0.00. The previous quarter’s sales results were €0.00. 1KA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 1KA has Performed in-line its overall industry.
Next quarter’s sales forecast for 1KA is €0.00 with a range of €0.00 to €0.00. The previous quarter’s sales results were €0.00. 1KA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 1KA has Performed in-line its overall industry.

1KA Stock Forecast FAQ

What is DE:1KA’s average 12-month price target, according to analysts?
Based on analyst ratings, GH Research’s 12-month average price target is 37.17.
    What is DE:1KA’s upside potential, based on the analysts’ average price target?
    GH Research has 53.59% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is GH Research a Buy, Sell or Hold?
          GH Research has a consensus rating of Strong Buy, which is based on 9 buy ratings, 0 hold ratings and 0 sell ratings.
            What is GH Research’s share price target?
            The average share price target for GH Research is 37.17. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €55.70 ,and the lowest forecast is €32.56. The average share price target represents 53.59% Increase from the current price of €24.2.
              What do analysts say about GH Research?
              GH Research’s analyst rating consensus is a Strong Buy. This is based on the ratings of 9 Wall Streets Analysts.
                How can I buy shares of GH Research?
                To buy shares of DE:1KA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.